To study Efficacy and safety of fractional CO2 laser with oral itraconazole SB versus oral itraconazole SB in treatment of onychomycosis among patients attending tertiary care hospital bhavnagar
Not Applicable
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2022/12/047953
- Lead Sponsor
- Khatri Dimple Nileshkumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients equal or more than 18 years of age, of either gender presenting with one or more finger nail onychomycosis.
Exclusion Criteria
Pregnant and lactating female
Patients with other nail disorders due to psoriasis ,chronic eczema ,lichen planus ,bacterial infection , subungual hematoma.
Patients who had used topical and systemic antifungal in the preceding 3 months.
Patients with SGOT and SGPT more than the normal range.
Patients with history of cardiac disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of fractional co2 laser with oral itraconazole SB in treatment of onychomycosis using Onychomycosis severity index <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: at baseline, 4 weeks, 8 weeks and 12 weeks <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method To assess the side effects of fractional CO2 laser and oral Itraconazole SB in treatment of onychomycosis <br/ ><br> <br/ ><br>Timepoint: At baseline, 4 weeks , 8 weeks and 12 weeks. <br/ ><br> <br/ ><br>